Status: Available
Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
This is an Intermediate-Size Expanded Access, Open-Label Study for Use of Mino-Lok Therapy (MLT) in Combination with Systemic Antibiotics in the Treatment of Central Line Associated Bloodstream Infection. Mino-Lok may be made available for patients who otherwise do not qualify for the phase 3 clinical trial (NCT02901717 )
Trial details
Age: 12+Biological sex: AllType: Expanded AccessSponsor: Leonard-Meron Biosciences, Inc.Updated: Aug 14, 2020Locations: 30
Eligibility criteria
Subject or a legally authorized representative must provide a signed informed co... [+5]
Subjects with hypersensitivity or allergy to tetracycline antibiotics or edetate... [+3]